
US aid cuts condemn hungry children abroad
Advertisement
Saving children with severe acute malnutrition is simple and inexpensive. Each packet costs less than 30 cents but contains a high-calorie mix of peanuts, sugar, milk powder and oil -- flavors appealing to children -- and a blend of vitamins and minerals. A complete six-week treatment for a severely malnourished child runs less than $45.
Advertisement
USAID funded roughly half the world's supply of ready-to-use therapeutic food, or RUTF, purchasing some directly from U.S. manufacturers and funding the United Nations Children Fund, or UNICEF, to manage its distribution.
All those grants were abruptly halted when the Trump administration froze foreign aid earlier this year. USAID eventually reimbursed grantees for costs already incurred.
The State Department recently authorized a $93 million new grant to UNICEF, but it is less than half what the government had typically spent. In 2024, the agency spent about $200 million on this work, not including aid for countries and direct grants to organizations that implement programs.
Funds for 2025 have yet to be released to manufacturers; the World Food Programme, which distributes a similar product for moderate acute malnutrition; those who transport the products; or the many organizations, like the International Rescue Committee or Helen Keller International, that run the malnutrition programs.
In response to questions from the Times, the State Department emailed a statement asserting that lifesaving malnutrition programs 'remain a priority.'
'Malnutrition treatment is among the first new obligations of foreign assistance funding,' the statement said.
But it also said that 'other actors -- including national governments and international humanitarian organizations -- must step up.'
President Trump has made the same argument for many aid programs, saying the United States should not have to carry the bulk of the burden of caring for the world. Although other countries do already contribute, and some organizations are scrambling to fill the gap, it is unlikely that they can do so quickly enough to help the children who are now in need.
Increasingly, some governments such as Nigeria, Kenya and Burkina Faso have been contributing by hosting factories that manufacture the packets. The Child Nutrition Fund, started by UNICEF, the British government and others, encourages governments to finance supply by offering a 1:1 match for every dollar.
Advertisement
Before the sudden withdrawal of aid, 'things were absolutely moving in the right direction,' said James Sussman, a spokesperson for the International Rescue Committee.
Now boxes containing millions of dollars' worth of the lifesaving packets are stuck at every link in the supply chain: in manufacturers' warehouses, at shipping companies, in cities that received the shipments and in treatment centers that have shut down all over the world.
In nearly a dozen countries, the supply chain for the packets has become so unstable that thousands of children are at high risk of dying, according to organizations that help distribute the treatments. Tens of thousands more could be in danger in the coming weeks and months if funds for this year do not move quickly.
'We have seen the mortality rates in the hospitals increasing by the day,' said Aliyu Mohammed Jabo, Helen Keller International's director for Nigeria. 'This is the ugly situation that we are facing because of this funding cut.'
In Nigeria, 150 clinics operated by the World Food Programme in Borno and Yobe states, which provided treatment for more than 300,000 children under the age of 2, shut down at the end of July. In Bauchi state, Helen Keller International has had to stop treating malnutrition in 16 of its 17 centers, leaving more than 17,000 children without treatment.
In eastern Chad, Mali and Niger, malnutrition treatments are unavailable or in dangerously short supply. Clinics in northeast Syria, Burkina Faso and Kenya have closed down. In South Sudan, the International Rescue Committee estimates that it will have to close 62 static treatment sites and nine mobile clinics if funding is not restored by September.
Advertisement
In Afghanistan, IRC warehouses are bare, despite 900,000 children who are in desperate need of treatment for severe acute malnutrition. Nepal has no supply in about half of its provinces and is facing a nationwide shortage starting this month, endangering about 200,000 malnourished children, including about 25,000 who are at risk of death.
Several other countries, including Congo, Ethiopia and Madagascar, similarly have only enough products to treat children for a few more weeks or months.
This month, after long delays, the State Department authorized $93 million for UNICEF, its first large grant for 2025, to supply RUTF to 12 African countries and Haiti. Part of the grant is for distributing 11,000 metric tons of packets, enough for about 800,000 children, to last through June 2026. Some money will also be spent to transport and distribute more than 1,200 metric tons of stalled packets -- enough for about 87,000 children.
But UNICEF expects that it will be two to three months before the products are delivered, according to Helen Wylie, a spokesperson for the organization.
After orders are placed and products manufactured, it can take months for treatments to reach people.
Secretary of State Marco Rubio has repeatedly said that no children have died as a result of the cuts to foreign aid and the dismantling of USAID, calling reports of any deaths 'false' and 'fake.'
But several organizations, including Doctors Without Borders and the aid group Action Against Hunger, have reported deaths in children related to malnutrition. More timely and precise estimates of deaths are difficult, because many of the programs that track children in need have shut down, and most organizations dare not speak up against the administration, fearing retaliation.
Advertisement
One global study has estimated that more than 160,000 children might die each year if the funds are not restored.
Acute malnutrition, also called wasting, is thought to affect about 43 million children worldwide. Even when aid flowed freely, it did not reach many of them. In 2023, RUTF was dispensed to 9.3 million children, according to UNICEF.
The first 1,000 days of life in particular are critical for brain development. Severely malnourished children have impaired immune responses, may suffer permanent cognitive damage and are more vulnerable to infections, even after treatment. They are up to 11 times as likely to die as a healthy child is. Severe wasting accounts for as many as 1 in 5 deaths of children younger than 5 worldwide.
By the time a child reaches a treatment center, he or she may have only hours to survive. 'It really comes down to the children who do not have time to waste,' said Navyn Salem, who runs Edesia Nutrition, one of two large U.S. manufacturers.
In previous years, American farmers supplied the raw ingredients -- peanuts, milk powder and soy -- to Edesia and Mana, two large U.S. manufacturers. The finished product was transported by truck to major U.S. ports, then shipped to the ports of Africa, where it would be unloaded and stored. An intricate network of organizations then transported and distributed the boxes.
The stop-start-stop of work orders and the dissolution of USAID has thrown the system into disarray. USAID's activities have in theory been transferred to the State Department, but the department has neither the personnel it needs to restart all activities -- even less so after widespread layoffs earlier this month -- nor the systems needed to release funds.
Advertisement
The department 'continues to strengthen internal systems and personnel capacity to ensure timely, accountable delivery of lifesaving humanitarian programs,' a representative of the State Department said in an email.
In the meantime, some organizations are burning through their reserves, but many small ones have folded.
Others are looking to philanthropy. Mana received a gift of $20 million from a British philanthropist and donated about 500,000 boxes to UNICEF. Edesia has raised $2 million in private funding and is shipping some boxes to the neediest sites on its own.
Without more funds, the companies will have no money left to buy raw materials and are in danger of defaulting on contracts from farmers in 25 states.
'The American farmers that we work with can only hold on for so long as well,' Salem said. 'So it's been a waiting game, a very stressful waiting game.'
Edesia recently shipped 122,000 boxes to Sudan and still has more than 185,000 at its warehouses. UNICEF will use the new funds to ship those products soon, according to the State Department. Mana, too, has already been paid for 400,000 boxes which have yet to ship; 100,000 are slated to move to South Sudan sometime in the coming weeks.
Even if funding were to resume tomorrow, it takes weeks to ship products to their destinations. For RUTF to reach locations in South Sudan, for example, the products must first be shipped to Mombasa, Kenya -- or produced locally in Kenya -- then transported by road through Kenya and Uganda to Juba, the capital, and then to more remote parts of the country.
The roads are rough, especially in the rainy season, and boxes may take two or three months to reach the sites, said Stephane Doyon, an operations manager for Doctors Without Borders. In Afghanistan, the time to delivery may stretch to eight or nine months, he said.
That may be too late for some children.
This article originally appeared in

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
GoHealth Second Quarter 2025 Earnings: Misses Expectations
Explore GoHealth's Fair Values from the Community and select yours GoHealth (NASDAQ:GOCO) Second Quarter 2025 Results Key Financial Results Revenue: US$94.0m (down 11% from 2Q 2024). Net loss: US$55.2m (loss widened by 105% from 2Q 2024). US$5.10 loss per share (further deteriorated from US$2.70 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period GoHealth Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 100%. Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in the US. Performance of the American Insurance industry. The company's share price is broadly unchanged from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 3 warning signs for GoHealth you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
4 hours ago
- Yahoo
US suspends visas for Gazans after far-right influencer posts
The US government said Saturday it is suspending visitor visas for Gazans after a far-right influencer with the ear of President Donald Trump complained that wounded Palestinians had been allowed to seek medical treatment in the United States. The announcement came one day after a series of furious social media posts by Laura Loomer, who is known for promoting racist conspiracy theories and claiming that the 9/11 terrorist attacks were an inside job. "All visitor visas for individuals from Gaza are being stopped while we conduct a full and thorough review of the process and procedures used to issue a small number of temporary medical-humanitarian visas in recent days," the State Department, which is led by Marco Rubio, wrote on X. In a series of posts on X Friday, Loomer called on the State Department to stop giving visas to Palestinians from Gaza who she said were "pro-HAMAS... affiliated with the Muslim Brotherhood and funded by Qatar," without providing evidence. Loomer's target was the US-based charity HEAL Palestine, which said last week it had helped 11 critically wounded Gazan children -- as well as their caregivers and siblings -- arrive safely in the US for medical treatment. It was "the largest single medical evacuation of injured children from Gaza to the US," the charity said on its website. - 'Dangerous and inhumane' - "Truly unacceptable," Loomer wrote in another X post. "Someone needs to be fired at @StateDept when @marcorubio figures out who approved the visas." "Qatar transported these GAZANS into the US via @qatarairways," she said. Qatar is "literally flooding our country with jihadis," she added. Loomer said she had spoken to the staff of Republican Tom Cotton, who chairs the Senate intelligence committee, adding that they were "also looking into how these GAZANS got visas to come into the US." Republican Congressman Randy Fine explicitly commended Loomer after the visa change was announced, in a sign of her sway over some US policy. "Massive credit needs to be given to @LauraLoomer for uncovering this and making me and other officials aware. Well done, Laura," Fine wrote on X. The Palestine Children's Relief Fund, a US-based charity, called on the Trump administration to "reverse this dangerous and inhumane decision." Over the last 30 years the charity has evacuated thousands of Palestinian children to the US for medical care, it said a statement. "Medical evacuations are a lifeline for the children of Gaza who would otherwise face unimaginable suffering or death due to the collapse of medical infrastructure in Gaza." Though Loomer holds no official position, she wields significant power, and is reported to have successfully pushed for the dismissal of several senior US security officials she deemed disloyal to Trump. In July, Loomer took aim at a job offer made to a highly qualified Biden-era official for a prestigious position at the West Point military academy. The Pentagon rescinded the offer one day later. Trump also fired the head of the highly sensitive National Security Agency, Timothy Haugh, and his deputy Wendy Noble in April at the apparent urging of Loomer, after she met with the president at the White House. "No other content creator or journalist has gotten as many Biden holdovers fired from the Trump admin!" Loomer posted on X Saturday. nr/dl/sla Solve the daily Crossword
Yahoo
7 hours ago
- Yahoo
Elevance Health (NYSE:ELV) Is Reinvesting At Lower Rates Of Return
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. Having said that, from a first glance at Elevance Health (NYSE:ELV) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. What Is Return On Capital Employed (ROCE)? For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Elevance Health, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.11 = US$8.7b ÷ (US$122b - US$44b) (Based on the trailing twelve months to June 2025). So, Elevance Health has an ROCE of 11%. By itself that's a normal return on capital and it's in line with the industry's average returns of 11%. See our latest analysis for Elevance Health In the above chart we have measured Elevance Health's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Elevance Health for free. What Does the ROCE Trend For Elevance Health Tell Us? In terms of Elevance Health's historical ROCE movements, the trend isn't fantastic. Around five years ago the returns on capital were 14%, but since then they've fallen to 11%. Although, given both revenue and the amount of assets employed in the business have increased, it could suggest the company is investing in growth, and the extra capital has led to a short-term reduction in ROCE. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run. The Bottom Line While returns have fallen for Elevance Health in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. These trends are starting to be recognized by investors since the stock has delivered a 16% gain to shareholders who've held over the last five years. Therefore we'd recommend looking further into this stock to confirm if it has the makings of a good investment. Elevance Health could be trading at an attractive price in other respects, so you might find our on our platform quite valuable. For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data